Live monthly · Next session November 3 · 1:00 PM ET

MedDevice AI Security Monthly.

The monthly MedTech AI cybersecurity webinar. AI moved faster than the guidance, and both are moving faster than most product security programs. Once a month we cover what actually changed: new FDA expectations when AI is in your device, the standards heading your way, and the discovery, testing and management techniques that are now table stakes.

Vendor neutral · not a product demoFDA AI cybersecurity guidanceAI standards for MedTechDiscovery and pentestingVulnerability management
Next · Tuesday, November 3, 2026 Time · 1:00 PM ET Cadence · Last Tuesday, monthly Host · Jason Sinchak, CEO
Save your seat
This month's panel

One Problem.
Multiple Perspectives.

The sector, a manufacturer, an engineer, and the people testing the products. Every session is a live discussion between all four, not a presentation with questions bolted on the end.

Jason Sinchak
CEO
ELTON

More than a decade testing medical devices, with 1,000+ vulnerability reports taken through FDA review.

Phil Englert
VP, Medical Device Security
Health-ISAC

The sector view. What medical device security actually looks like across Health-ISAC member organizations, rather than inside any one of them.

Oleg Yusim
VP, Product Security
Illumina

Product security from inside a manufacturer, where the findings land and the fixes have to be scheduled against a roadmap.

Shehadeh Dajani
Software Engineer
TripleRing

The engineering seat. Where security meets the constraints of actually designing and shipping a working device.

From the series

Start with session one.

Session one aired September 1 on what AI-driven discovery does to a medical device backlog, and what an evidenced disposition actually takes. It is recorded and yours to keep. Watch it before November 3 and you arrive with the context the monthly sessions build on.

PUBLISHED CVES PER YEAR AI-driven projection 0K25K50K75K100K125K 2017201920212023202520272028 actual projected Roughly 3x today’s volume within four years. Every one of them still needs a disposition on your product.
Published CVEs per year, historical through 2024 and AI-driven projection to 2028. Roughly 3x today's volume in four years.
What each session covers

Six things we explore every month.

This is a working session, not a keynote. If your security or regulatory team has to answer for AI in your product, this is where the month gets explained.

New FDA AI cybersecurity guidance

What the agency expects when AI is in your product, and what that means for a program built before any of it existed.

What to do in premarket design

The AI design decisions you need to make early. Leave them until submission time and they get expensive.

What has to be evidenced

Which AI decisions have to be documented, what reviewers ask for, and what a defensible AI cybersecurity package actually contains.

New AI cyber standards

The standards heading for MedTech, what each will require, and how far ahead of the deadline you need to start moving.

Discovery and pentesting

How discovery is being done now, techniques from real engagements, what AI driven testing reaches that manual testing does not, and where it still needs a human.

AI vulnerability management

Triage and disposition methods that survive the volume AI discovery produces, with evidence attached to every call.

Who should attend

Bring people who get asked about AI.

Product security and engineering

The teams choosing where AI sits in the product and who will own whatever the testing surfaces. They want the techniques and the finding volume, not the summary.

Regulatory and quality

The teams who have to describe AI in a submission and answer the reviewer's follow-up. They want to know what has to be evidenced, and when.

Cannot make every month? Register once and come to the sessions that matter to you. The recording goes to everyone who signed up, every time.
Next session · November 3, 2026

Save your seat.

Register for the months that touch your roadmap, skip the ones that do not, and the recording lands either way.

Questions

Common questions about MedDevice AI Security Monthly.

How often does this run?

Monthly at 1:00 PM ET, normally the last Tuesday of the month, running about an hour including questions. The next session is Tuesday, November 3, 2026, hosted by Jason Sinchak, CEO and co-founder of ELTON Cyber. There is no December session, because the last Tuesday of December falls between Christmas and New Year. The series resumes Tuesday, January 26, 2027.

Do I have to register every month?

Yes. Each month is its own registration, so your confirmation carries a calendar invite and a join link for that session. Register for the sessions that are relevant to what you are building.

Is this a product demo?

No. The session is vendor neutral. It covers techniques, standards and regulatory expectations for AI in medical devices, not a walkthrough of the ELTON platform. If ELTON comes up it is because somebody in the room asked.

What does each session cover?

Six recurring areas: new FDA AI cybersecurity guidance, what to do early in premarket design when AI is going into your product, what has to be evidenced for a regulatory submission, new AI cyber standards heading for MedTech, AI vulnerability discovery and pentesting techniques, and AI vulnerability management methods. Each month the material is rebuilt from what actually changed.

Who should attend?

Product security and engineering teams choosing where AI sits in the product and owning what the testing surfaces, and regulatory and quality teams who have to describe AI in a submission and answer the reviewer's follow-up. Providers and consultants are welcome too.

Is there a replay?

Yes. Registrants get the recording after each session, and every past session sits in the recordings archive, where one short form unlocks all the recordings and slides.

How does this relate to the newsletter?

MedDevice AI Security Weekly is the weekly read and this is the monthly session. Registering for the webinar also subscribes you to the newsletter, and you can unsubscribe from either at any time.

Exploitability management for medical devices. FDA §524B methodologyExploitability proven at runtime95% faster than legacy testing Book a Demo →
Platform
OverviewAvoid FDA DeficienciesAvoid Consulting FeesDigital Twin TraceabilityAI MedDevice PentestingExploitability VerificationVulnerability ChainingRemediation OptimizationRemote TestLink™Incident ResponseAutomated VEX & MetricsCVSSv4 Migration
Solutions
EnterpriseStartups / SMBs Postmarket SurveillanceIncident ResponseSecurity EngineeringRegulatory AffairsFDA §524BEU MDR/CRAEU REDNIS2IMDRF N60 / N73Japan MHLW
Why ELTON
Proof over ProbabilityExploitability VerificationFDA-Qualified CVSSv3CVSSv4 MigrationQMSR Audit ComplianceAI-Enabled Device Testing One SolutionSubscription TestingAI-NativeELTON vs. Legacy TestingThreat-Led AI PentestingCredentialsDevice ModalitiesPricing
Resources
FDA Deficiency ListFDA Testing RequirementsFDA Cyber SOPs & TemplatesRemediation LibraryRegulatory GuidesWebinarsAI NewsletterThe End of Legacy TestingThe AI Vulnerability ExplosionAI Inside the ProductCybersecurity TestingSecurity AdvisoriesWhitepapersIntelligence & Blog
Company
AboutLeadershipCareersPartnershipsData SecurityContact Meet ELTON →